Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Safety and Tolerability Open-Label Study of Interferon Beta-1b in Combination With Tacrolimus in Patients Suffering From Multiple Sclerosis Who Have Failed Treatment With Approved Disease Modifying Agents

NCT00298662 is registered in ClinicalTrials.gov with Clinique de sclérose en plaques et neuromusculaire de l'Outaouais as lead sponsor.

NCT NCT00298662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00298662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Safety and Tolerability Open-Label Study of Interferon Beta-1b in Combination With Tacrolimus in Patients Suffering From Multiple Sclerosis Who Have Failed Treatment With Approved Disease Modifying Agents
Lead sponsor
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2003
Completion date
September 30, 2006
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis